- Home
- ODYS vs XBIT Comparison
ODYS vs XBIT Comparison
Compare ODYS & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODYS
- XBIT
- Stock Information
- Founded
- ODYS N/A
- XBIT 2005
- Country
- ODYS Israel
- XBIT United States
- Employees
- ODYS N/A
- XBIT N/A
- Industry
- ODYS
- XBIT Pharmaceuticals and Biotechnology
- Sector
- ODYS
- XBIT Health Care
- Exchange
- ODYS NYSE
- XBIT Nasdaq
- Market Cap
- ODYS 86.1M
- XBIT 89.6M
- IPO Year
- ODYS N/A
- XBIT 2015
- Fundamental
- Price
- ODYS $5.00
- XBIT $3.18
- Analyst Decision
- ODYS Strong Buy
- XBIT
- Analyst Count
- ODYS 1
- XBIT 0
- Target Price
- ODYS $10.00
- XBIT N/A
- AVG Volume (30 Days)
- ODYS 12.0K
- XBIT 187.9K
- Earning Date
- ODYS 08-11-2025
- XBIT 08-11-2025
- Dividend Yield
- ODYS N/A
- XBIT N/A
- EPS Growth
- ODYS N/A
- XBIT N/A
- EPS
- ODYS N/A
- XBIT N/A
- Revenue
- ODYS $5,842,000.00
- XBIT N/A
- Revenue This Year
- ODYS N/A
- XBIT N/A
- Revenue Next Year
- ODYS N/A
- XBIT N/A
- P/E Ratio
- ODYS N/A
- XBIT N/A
- Revenue Growth
- ODYS 100.27
- XBIT N/A
- 52 Week Low
- ODYS $4.00
- XBIT $2.50
- 52 Week High
- ODYS $10.80
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- ODYS N/A
- XBIT 63.47
- Support Level
- ODYS N/A
- XBIT $2.58
- Resistance Level
- ODYS N/A
- XBIT $3.32
- Average True Range (ATR)
- ODYS 0.00
- XBIT 0.17
- MACD
- ODYS 0.00
- XBIT 0.07
- Stochastic Oscillator
- ODYS 0.00
- XBIT 82.93
About ODYS ODYSIGHT AI INC
Odysight ai Inc is engaged in the development, production, and marketing of Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) technologies, providing visual sensing and AI-based video analytics solutions for critical systems in the aviation, maritime, industrial non-destructing-testing industries, transportation, and energy industries.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.